Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synthesis and Biological Evaluation of Fused Tricyclic Heterocycle Piperazine (Piperidine) Derivatives As Potential Multireceptor Atypical Antipsychotics
Xudong Cao, Yifang Zhang, Yin Chen, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 22, pp. 10017-10039
Closed Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Piperidine nucleus in the field of drug discovery
Mennatallah Mahmoud Abdelshaheed, Iten M. Fawzy, Hussein I. El‐Subbagh, et al.
Future Journal of Pharmaceutical Sciences (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 87
Piperazine skeleton in the structural modification of natural products: a review
Run-Hui Zhang, Hongyan Guo, Hao Deng, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2021) Vol. 36, Iss. 1, pp. 1165-1197
Open Access | Times Cited: 75
Development in the Synthesis of Bioactive Thiazole-Based Heterocyclic Hybrids Utilizing Phenacyl Bromide
Ginna Kumari, Sudeep Dhillon, Priyanka Rani, et al.
ACS Omega (2024) Vol. 9, Iss. 17, pp. 18709-18746
Open Access | Times Cited: 13
Utility of 2-Chloro-N-arylacetamide and 1,1′-(Piperazine-1,4-diyl)bis(2-chloroethanone) as Versatile Precursors for Novel Mono- and Bis[thienopyridines]
Mostafa E. Salem, Abbas H. Abdullah, Magdi E. A. Zaki, et al.
ACS Omega (2024) Vol. 9, Iss. 9, pp. 10146-10159
Open Access | Times Cited: 8
Synthesis and antimicrobial evaluation of a new hybrid bis-cyanoacrylamide-based-piperazine containing sulphamethoxazole moiety against rheumatoid arthritis-associated pathogens
Mona M. Soliman, Ahmed H. M. Elwahy, Ahmed M. Sayed, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Open Access | Times Cited: 1
Synthesis, docking, and biological investigations of new coumarin-piperazine hybrids as potential antibacterial and anticancer agents
Kajalben B. Patel, Sudipta Mukherjee, Hardik Bhatt, et al.
Journal of Molecular Structure (2022) Vol. 1276, pp. 134755-134755
Closed Access | Times Cited: 29
Advances in structure-based drug design: The potential for precision therapeutics in psychiatric disorders
Dongmei Cao, Pei Zhang, Sheng Wang
Neuron (2024) Vol. 112, Iss. 4, pp. 526-538
Closed Access | Times Cited: 6
Synthesis, molecular docking simulation, and antimicrobial activities of novel bis-heterocycles linked to piperazine and vanillin units as novel hybrid molecules via Hantzsch, Biginelli, and Michael’s reactions
Ibrahim M. Z. Fares, Nesma E. Mahmoud, Ismail A. Abdelhamid, et al.
Results in Chemistry (2024) Vol. 10, pp. 101684-101684
Open Access | Times Cited: 6
Exploring the Potential of Coumarin Derivatives on Serotonin Receptors 5-HT1A and 5HT2A
Kinga Ostrowska, Gabriela Horosz, Karolina Kruk, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1946-1946
Open Access
N‐Heterocyclic Carbene Catalyzed Concerted Nucleophilic Aromatic Substitution of Aryl Fluorides Bearing α,β‐Unsaturated Amides
Kosuke Yasui, Miharu Kamitani, Mamoru Tobisu
Angewandte Chemie International Edition (2019) Vol. 58, Iss. 40, pp. 14157-14161
Closed Access | Times Cited: 42
Accelerating Drug Discovery by Early Protein Drug Target Prediction Based on a Multi-Fingerprint Similarity Search †
Michele Montaruli, Domenico Alberga, Fulvio Ciriaco, et al.
Molecules (2019) Vol. 24, Iss. 12, pp. 2233-2233
Open Access | Times Cited: 40
Computational approaches for the design of novel dopamine D2 and serotonin 5-HT2A receptor dual antagonist towards schizophrenia
Akash Rathore, Vivek Asati, Mitali Mishra, et al.
In Silico Pharmacology (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 20
Construction of 3,4-Dihydroquinolone Derivatives through Pd-Catalyzed [4+2] Cycloaddition of Vinyl Benzoxazinanones with α-Alkylidene Succinimides
Ting-Ting Yu, Peng-Ting Huang, Ben‐Hong Chen, et al.
The Journal of Organic Chemistry (2024) Vol. 89, Iss. 5, pp. 3279-3291
Closed Access | Times Cited: 4
Design, Synthesis, In Vitro Anticancer and ADMET Studies of Piperazine-Pyrazolo-Quinoxalin-2(1H)-one Conjugate as EGFR Targeting Agents
Mohammad Ferazoddin, Arshiya Banu Syeda, Asra Banu Syeda, et al.
Russian Journal of General Chemistry (2025) Vol. 95, Iss. 1, pp. 184-195
Closed Access
Facile synthesis and antimicrobial activity of bis(fused 4H‐pyrans) incorporating piperazine as novel hybrid molecules: Michael's addition approach
Mostafa E. Salem, Ibrahim M. Z. Fares, Said A. S. Ghozlan, et al.
Journal of Heterocyclic Chemistry (2022) Vol. 59, Iss. 11, pp. 1907-1926
Closed Access | Times Cited: 17
Recent advances in dopamine D2 receptor ligands in the treatment of neuropsychiatric disorders
Radomír Jůza, Kamil Musílek, Eva Mezeiová, et al.
Medicinal Research Reviews (2022) Vol. 43, Iss. 1, pp. 55-211
Closed Access | Times Cited: 17
An insight into the biological activity and structure-based drug design attributes of sulfonylpiperazine derivatives
Jaydeo T. Kilbile, Yasinalli Tamboli, Suchita S. Gadekar, et al.
Journal of Molecular Structure (2023) Vol. 1278, pp. 134971-134971
Closed Access | Times Cited: 10
Design, synthesis, molecular docking, molecular dynamic simulation, and MMGBSA analysis of 7-O-substituted 5-hydroxy flavone derivatives
Kajalben B. Patel, Rahul V. Patel, Iqrar Ahmad, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 12, pp. 6378-6392
Open Access | Times Cited: 9
New quinoxaline‐piperazine‐oxazole conjugates: Synthesis, in vitro anticancer, in silico ADMET, and molecular docking studies
Mohammad Ferazoddin, Siddhartha Marupati, Gouthami Dasari, et al.
Journal of Heterocyclic Chemistry (2024) Vol. 61, Iss. 4, pp. 627-641
Closed Access | Times Cited: 3
Recent advances in multitarget-directed ligands targeting G-protein-coupled receptors
Hongguang Ma, Boshi Huang, Yan Zhang
Drug Discovery Today (2020) Vol. 25, Iss. 9, pp. 1682-1692
Open Access | Times Cited: 27
Pharmacology profile of F17464, a dopamine D3 receptor preferential antagonist
Cristina Cosi, Jean‐Claude Martel, Agnès L. Auclair, et al.
European Journal of Pharmacology (2020) Vol. 890, pp. 173635-173635
Closed Access | Times Cited: 20
Discovery of Novel and Potent N-Methyl-d-aspartate Receptor Positive Allosteric Modulators with Antidepressant-like Activity in Rodent Models
Zhongtang Li, Guanxing Cai, Fang Fan, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 9, pp. 5551-5576
Closed Access | Times Cited: 17
Effect of Co-Treatment of Olanzapine with SEP-363856 in Mice Models of Schizophrenia
Lingzhi Liang, Xia Ren, Junyi Xu, et al.
Molecules (2022) Vol. 27, Iss. 8, pp. 2550-2550
Open Access | Times Cited: 11
Research progress of piperazine and morpholine derivatives in the discovery of agricultural chemicals
Yong Zhang, Xing Liu, Yue Zou, et al.
Journal of Heterocyclic Chemistry (2023) Vol. 60, Iss. 11, pp. 1826-1837
Closed Access | Times Cited: 6
Transition-Metal- and Light-Free Generation of an Iminyl Radical: Facile Approach to Oxindoles and Isoquinolinediones with a Quaternary Carbon Center via Cyanoalkylarylation
Lanjun Su, Pan Xue, Xin Zhu, et al.
The Journal of Organic Chemistry (2021) Vol. 87, Iss. 1, pp. 874-883
Closed Access | Times Cited: 15
Page 1 - Next Page

Scroll to top